Could a product sold as a dietary supplement really be delivering the benefits that advocates have claimed for decades? That’s what you might be wondering about coenzyme Q10, following recent stories like:
- The energy-boosting supplement that could HALVE the number of deaths from heart failure screamed The Daily Mail.
- It’s Official: Coenzyme Q10 Improves Heart Failure Survival from the “orthomolecular” advocates AOR.
- Could Antioxidant Supplement Cut Heart Failure Risk? asked eMaxHealth.
- First Drug to Significantly Improve Heart Failure Mortality in Over a Decade from Live Science.
- Could supplements be the key to boosting survival from heart failure? asked WebMD.
What’s caused all the excitement about CoQ10 is the Q-SYMBIO trial, more properly called “The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure”, presented at the European Society of Cardiology conference last month. I’d normally wait for the full article to come out, and will review it if possible at that time, but the results are too interesting to ignore so I’ll dive into the study and the reaction – which is equally as interesting as a lesson in why scientific skepticism is so important. Continue reading
You must be logged in to post a comment.